Vanda Pharmaceuticals (VM4.F) Q2 2025 Earnings

7MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.51
-0.36
-0.22
-0.07

Details

Expected EPS
-0.50692383861
Actual EPS
-0.442085
Surprise EPS
0.06
Surprise Percent
+12.79%

Description

Vanda Pharmaceuticals (VM4.F) has reported earnings of -0.442085 per share for Q2 2025.

0 Comments

Share your thoughts